Total genomic alteration as measured by SNP-array-based molecular karyotyping is predictive of overall survival in a cohort of MDS or AML patients treated with azacitidine

Metaphase cytogenetics (MC) has a major role in the risk stratification of patients with myelodysplastic syndromes (MDSs) and can affect the choice of therapies. Azacitidine (AZA) has changed the outcome of patients with MDS or acute myeloid leukemia (AML) unfit for intensive chemotherapy. Identific...

Descripción completa

Detalles Bibliográficos
Autores principales: Cluzeau, T, Moreilhon, C, Mounier, N, Karsenti, J-M, Gastaud, L, Garnier, G, Re, D, Montagne, N, Gutnecht, J, Auberger, P, Fuzibet, J G, Cassuto, J-P, Raynaud, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880435/
https://www.ncbi.nlm.nih.gov/pubmed/24185502
http://dx.doi.org/10.1038/bcj.2013.52

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880435/
https://www.ncbi.nlm.nih.gov/pubmed/24185502
http://dx.doi.org/10.1038/bcj.2013.52

Ejemplares similares